sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Asia Pacific Pharmaceutical Manufacturing Industry 2020-2027 by Formulation, Route of Administration, Age Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Country: Trend Forecast and Growth Opportunity

Asia Pacific Pharmaceutical Manufacturing Industry 2020-2027 by Formulation, Route of...

Home / Categories / Healthcare
Asia Pacific Pharmaceutical Manufacturing Industry 2020-2027 by Formulation, Route of Administration, Age Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Country: Trend Forecast and Growth Opportunity
Asia Pacific Pharmaceutical Manufacturing Industry...
Report Code
RO1/105/1113

Publish Date
28/Mar/2024

Pages
130
PRICE
$ 2700/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 4000/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 5400/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Table 1. Snapshot of Asia Pacific Pharmaceutical Manufacturing Industry in Balanced Perspective, 2020-2027 18
Table 2. Growth Rate of World Real GDP, 2017-2021 22
Table 3. Main Product Trends and Industry Opportunities in Asia Pacific Pharmaceutical Manufacturing Industry 32
Table 4. Asia Pacific Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn 40
Table 5. Asia Pacific Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn 49
Table 6. Asia Pacific Pharmaceutical Manufacturing Industry by Age Group, 2017-2027, $ bn 56
Table 7. Asia Pacific Pharmaceutical Manufacturing Industry by Therapeutic Application, 2017-2027, $ bn 61
Table 8. Asia Pacific Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn 71
Table 9. Asia Pacific Pharmaceutical Manufacturing Industry by Distribution Channels, 2017-2027, $ bn 76
Table 10. Asia Pacific Pharmaceutical Manufacturing Industry by Manufacturing Facility, 2017-2027, $ bn 80
Table 11. APAC Pharmaceutical Manufacturing Industry by Country, 2017-2027, $ bn 85
Table 12. China Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn 88
Table 13. China Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn 88
Table 14. China Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn 88
Table 15. Japan Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn 91
Table 16. Japan Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn 91
Table 17. Japan Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn 91
Table 18. India Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn 93
Table 19. India Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn 93
Table 20. India Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn 93
Table 21. Australia Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn 95
Table 22. Australia Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn 95
Table 23. Australia Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn 95
Table 24. South Korea Pharmaceutical Manufacturing Industry by Formulation, 2017-2027, $ bn 97
Table 25. South Korea Pharmaceutical Manufacturing Industry by Route of Administration, 2017-2027, $ bn 97
Table 26. South Korea Pharmaceutical Manufacturing Industry by Drug Type, 2017-2027, $ bn 97
Table 27. Pharmaceutical Manufacturing Industry in Rest of APAC by Country/Region, 2017-2027, $ bn 99
Table 28. Abbott Laboratories: Company Snapshot 104
Table 29. Abbott Laboratories: Business Segmentation 104
Table 30. Abbott Laboratories: Product Portfolio 105
Table 31. Abbott Laboratories: Revenue, 2017-2019, $ bn 105
Table 32. Risk Evaluation for Investing in Asia Pacific Industry, 2020-2027 125
Table 33. Critical Success Factors and Key Takeaways 128


LIST OF FIGURE
Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Industry Estimation 15
Figure 4. Asia Pacific Industry Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 17
Figure 5. Asia Pacific Pharmaceutical Manufacturing Industry, 2017-2027, $ bn 20
Figure 6. Impact of COVID-19 on Business 24
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Pharmaceutical Manufacturing Industry 26
Figure 8. Primary Restraints and Impact Factors of Asia Pacific Pharmaceutical Manufacturing Industry 29
Figure 9. Investment Opportunity Analysis 33
Figure 10. Porter's Fiver Forces Analysis of Asia Pacific Pharmaceutical Manufacturing Industry 36
Figure 11. Breakdown of Asia Pacific Pharmaceutical Manufacturing Industry by Formulation, 2020-2027, % of Revenue 41
Figure 12. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Formulation, Value ($ bn) and Share (%) 41
Figure 13. Asia Pacific Pharmaceutical Manufacturing Industry: Tablets, 2017-2027, $ bn 42
Figure 14. Asia Pacific Pharmaceutical Manufacturing Industry: Capsules, 2017-2027, $ bn 43
Figure 15. Asia Pacific Pharmaceutical Manufacturing Industry: Injectable, 2017-2027, $ bn 44
Figure 16. Asia Pacific Pharmaceutical Manufacturing Industry: Sprays, 2017-2027, $ bn 45
Figure 17. Asia Pacific Pharmaceutical Manufacturing Industry: Suspensions, 2017-2027, $ bn 46
Figure 18. Asia Pacific Pharmaceutical Manufacturing Industry: Powders, 2017-2027, $ bn 47
Figure 19. Asia Pacific Pharmaceutical Manufacturing Industry: Other Formulations, 2017-2027, $ bn 48
Figure 20. Breakdown of Asia Pacific Pharmaceutical Manufacturing Industry by Route of Administration, 2020-2027, % of Revenue 50
Figure 21. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Route of Administration, Value ($ bn) and Share (%) 50
Figure 22. Asia Pacific Pharmaceutical Manufacturing Industry: Oral Medicine, 2017-2027, $ bn 51
Figure 23. Asia Pacific Pharmaceutical Manufacturing Industry: Topical Medicine, 2017-2027, $ bn 52
Figure 24. Asia Pacific Pharmaceutical Manufacturing Industry: Parenteral Medicine, 2017-2027, $ bn 53
Figure 25. Asia Pacific Pharmaceutical Manufacturing Industry: Inhalations, 2017-2027, $ bn 54
Figure 26. Asia Pacific Pharmaceutical Manufacturing Industry: Other Routes of Administration, 2017-2027, $ bn 55
Figure 27. Breakdown of Asia Pacific Pharmaceutical Manufacturing Industry by Age Group, 2020-2027, % of Revenue 56
Figure 28. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Age Group, Value ($ bn) and Share (%) 57
Figure 29. Asia Pacific Pharmaceutical Manufacturing Industry: Children & Adolescents, 2017-2027, $ bn 58
Figure 30. Asia Pacific Pharmaceutical Manufacturing Industry: Adults, 2017-2027, $ bn 59
Figure 31. Asia Pacific Pharmaceutical Manufacturing Industry: Geriatric, 2017-2027, $ bn 60
Figure 32. Breakdown of Asia Pacific Pharmaceutical Manufacturing Industry by Therapeutic Application, 2020-2027, % of Revenue 62
Figure 33. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%) 62
Figure 34. Asia Pacific Pharmaceutical Manufacturing Industry: Cardiovascular Diseases, 2017-2027, $ bn 63
Figure 35. Asia Pacific Pharmaceutical Manufacturing Industry: Pain, 2017-2027, $ bn 64
Figure 36. Asia Pacific Pharmaceutical Manufacturing Industry: Diabetes, 2017-2027, $ bn 65
Figure 37. Asia Pacific Pharmaceutical Manufacturing Industry: Cancer, 2017-2027, $ bn 66
Figure 38. Asia Pacific Pharmaceutical Manufacturing Industry: Respiratory Diseases, 2017-2027, $ bn 67
Figure 39. Asia Pacific Pharmaceutical Manufacturing Industry: Neurological Diseases, 2017-2027, $ bn 68
Figure 40. Asia Pacific Pharmaceutical Manufacturing Industry: Orthopedics, 2017-2027, $ bn 69
Figure 41. Asia Pacific Pharmaceutical Manufacturing Industry: Other Applications, 2017-2027, $ bn 70
Figure 42. Breakdown of Asia Pacific Pharmaceutical Manufacturing Industry by Drug Type, 2020-2027, % of Revenue 71
Figure 43. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%) 72
Figure 44. Asia Pacific Pharmaceutical Manufacturing Industry: Branded Prescription Drugs, 2017-2027, $ bn 73
Figure 45. Asia Pacific Pharmaceutical Manufacturing Industry: Generic Prescription Drugs, 2017-2027, $ bn 74
Figure 46. Asia Pacific Pharmaceutical Manufacturing Industry: OTC Drugs, 2017-2027, $ bn 75
Figure 47. Breakdown of Asia Pacific Pharmaceutical Manufacturing Industry by Distribution Channels, 2020-2027, % of Revenue 76
Figure 48. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Distribution Channels, Value ($ bn) and Share (%) 77
Figure 49. Asia Pacific Pharmaceutical Manufacturing Industry: Retail Channels, 2017-2027, $ bn 78
Figure 50. Asia Pacific Pharmaceutical Manufacturing Industry: Non-retail Channels, 2017-2027, $ bn 79
Figure 51. Breakdown of Asia Pacific Pharmaceutical Manufacturing Industry by Manufacturing Facility, 2020-2027, % of Revenue 81
Figure 52. Contribution to Asia Pacific 2021-2027 Cumulative Revenue by Manufacturing Facility, Value ($ bn) and Share (%) 81
Figure 53. Asia Pacific Pharmaceutical Manufacturing Industry: In-house Facility, 2017-2027, $ bn 82
Figure 54. Asia Pacific Pharmaceutical Manufacturing Industry: Outsourced Facility, 2017-2027, $ bn 83
Figure 55. Breakdown of APAC Pharmaceutical Manufacturing Industry by Country, 2020 and 2027, % of Revenue 85
Figure 56. Contribution to APAC 2021-2027 Cumulative Revenue by Country, Value ($ bn) and Share (%) 86
Figure 57. Pharmaceutical Manufacturing Industry in China, 2017-2027, $ bn 87
Figure 58. Pharmaceutical Manufacturing Industry in Japan, 2017-2027, $ bn 90
Figure 59. Pharmaceutical Manufacturing Industry in India, 2017-2027, $ bn 92
Figure 60. Pharmaceutical Manufacturing Industry in Australia, 2017-2027, $ bn 94
Figure 61. Pharmaceutical Manufacturing Industry in South Korea, 2017-2027, $ bn 96
Figure 62. Pharmaceutical Manufacturing Industry in Rest of APAC, 2017-2027, $ bn 98
Figure 63. Growth Stage of Asia Pacific Industrial Robot Software Industry over the Forecast Period 100


?

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com